Skip to main content
SpringerLink
Log in

GnRH agonists: US FDA reviews CV safety

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Drug Safety Communication: Ongoing Safety Review of GnRH Agonists and possible increased risk of diabetes and certain cardiovascular diseases. Internet Document: [3 pages], 5 Mar 2010. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

GnRH agonists: US FDA reviews CV safety. React. Wkly. 1300, 1 (2010). https://doi.org/10.2165/00128415-201013000-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013000-00001

Keywords

Search

Navigation